EcoDrugPlus

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSSLUG00000007543
Gene Symbol: INPP5D
1 Cross references
215 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSSLUG00000023057
Gene Symbol: IGF1R
3 Cross references
204 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSSLUG00000023795
Gene Symbol: INSRA
1 Cross references
212 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSSLUG00000014921
Gene Symbol: LOC116055274
3 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSSLUG00000025493
Gene Symbol: IGF1RB
1 Cross references
203 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSSLUG00000021375
Gene Symbol: LOC116043745
3 Cross references
206 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSSLUG00000000540
Gene Symbol: ITGB3B
1 Cross references
194 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSSLUG00000019938
Gene Symbol: LOC116044937
3 Cross references
228 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSSLUG00000019734
Gene Symbol: LOC116064866
3 Cross references
213 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSSLUG00000016880
Gene Symbol: LOC116063920
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSSLUG00000000735
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSSLUG00000020250
Gene Symbol: ITGA5
1 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).